We observed that only WT1 (Wilms tumor protein), CALR (calreticulin), CAV1 (caveolin1), and proto-oncogene Myc (MYC) gene expression in all APL patients with no relapse history was significantly downregulated after treatment with all-trans retinoic acid and idarubicin. The gene discussed is CAV1; the disease is acute promyelocytic leukemia.